Section 1
Key takeaways
• A demo is the second half of diagnosis, not a separate act. Its job is to confirm the buyer's problems on screen, in their priority order and their language. • Gong Labs' analysis of 67,149 demos found that winning demos run 30.5% longer (47 vs 36 minutes), not because reps show more features, but because they go deeper on fewer, discovery-anchored problems. • Personalization is the lever with the cleanest data: teams that tailor 50% or more of their demos see 40%+ higher conversions than teams using generic templates . • The discipline rule is "no slide without a symptom." If a screen doesn't map to a problem the buyer stated in discovery, it doesn't get shown. • For enterprise deals over $50K ACV, guided demos convert at 55–75% versus 10–15% for self-serve trials, the difference is diagnosis, not product access.
Section 2
Why generic demos lose, mechanically
Start with what a buyer is actually doing when they sit through a demo. They are not evaluating your product in the abstract. They are checking one thing: did this person understand my problem well enough to solve it? The demo is the test, and the answer is encoded in what you choose to show. When you open with a tour, you fail that test in the first ninety seconds. You signal that the product has a fixed story it wants to tell, and the buyer's situation is an input to be processed later, if at all. The features you show that nobody asked about aren't neutral, they're evidence that you weren't listening, or worse, that you don't have a confident read on what matters here. A buyer watching an unrequested feature parade is quietly downgrading you the whole time. This is why the "show everything" instinct backfires. The logic feels safe: more surface area, more chances something lands. But each off-target screen dilutes the two or three that actually matter, and it lengthens the time before the buyer hears their own problem named back to them. Coverage is not the same as relevance, and buyers are optimizing for relevance. The data lines up with the mechanism. Walnut's platform data, drawn across thousands of B2B sales cycles, shows that teams personalizing at least half their demos convert 40%+ higher than teams running generic templates . Even holding the format constant, tailoring wins: interactive demos, ones a buyer can navigate against their own context, drive 32% higher conversion than static or live-only approaches . The thing being rewarded in both numbers is the same: a demo built around the buyer rather than the product. Getting this sequence right is downstream of getting the diagnosis right in the first place, the discipline we cover in the diagnostic discovery call. A demo can only be as targeted as the discovery it inherits.
Section 3
What does a demo actually inherit from discovery?
A demo is not where you learn what hurts. That work happens earlier, and the quality of it sets the ceiling on everything the demo can do. Gong's analysis of more than 519,000 B2B sales call recordings found a defined optimal range for discovery: ask between 11 and 14 targeted questions, and your success rate holds; push past that, and it drops back to average . Targeted is the operative word, these are problem-focused questions, not a survey. What you walk out of discovery with, done right, is a ranked list. Not a flat set of "things the buyer mentioned," but an ordered hierarchy: this is the problem they spent the most airtime on, this is the second, this is the third, and below a line, things they noted but didn't dwell on. That ranking is the most valuable artifact in the deal, because it tells you the exact order in which to show your product. Most reps throw that artifact away. They run a clean, thorough discovery call, then deliver the same demo they'd give anyone, sequenced by their own sense of what's impressive. The hierarchy the buyer built, for free, in their own words, gets ignored in favor of a feature order set by product marketing. That's the waste this article is about. You already extracted the priority list. The only remaining job is to honor it on screen. If your discovery is shaky to begin with, fix that first, the problem-first qualification approach in LeadOS is what produces a hierarchy worth following.
Section 4
The "upside-down pyramid": sequence by pain, not by polish
Here's the structural reframe, and it comes straight from the Gong research. Most reps build a demo like a movie: open with something solid, save the "best" feature for a grand finale, end on a high. Winners invert it. They front-load the heaviest problem and let the demo descend in priority from there. Gong's research team put the rule plainly: "The first part of your product demo should correlate with the business problem you spent the most time on during discovery. The second part of your sales demo should correlate with the business problem you spent the second most time on during discovery." Read that twice, because it quietly demolishes the standard demo script. The sequence isn't determined by your product's architecture, your onboarding flow, or which feature wins awards. It's determined entirely by where the buyer spent their attention in discovery. The demo is an "upside-down pyramid": widest, heaviest, most-talked-about problem first; everything else in descending order of how much the buyer dwelt on it. This solves the finale problem too. Saving your best for last assumes the buyer stays fully engaged for forty-five minutes and rewards you with a strong final impression. They don't. Attention is highest at the open and decays. If the thing they care about most shows up at minute thirty-eight, you've spent your best attention-minutes on problems they ranked lower, and you've made them wait to hear their own pain named. Lead with it instead. Confirm the diagnosis while they're still leaning in. And note what the length data is really telling you. Winning demos ran 30.5% longer, 47 minutes versus 36, but the Gong authors are careful to say this likely reflects naturally extended conversation, not feature-heavy pitching. That distinction matters. The winners didn't run long because they crammed in more screens. They ran long because going deep on the buyer's top problem generates real back-and-forth, questions, edge cases, "what about when…", and that conversation is the demo working, not padding. A short demo is often a sign nobody cared enough to dig in.
Section 5
A worked example: the bookkeeping firm's software demo
Make it concrete. Say you sell practice-management software to accounting and bookkeeping firms, and you're demoing to a 12-person firm's managing partner. In discovery, three problems surfaced, and they were not equally weighted. The partner spent most of the call on one thing: client document chasing. Their team burns hours every month emailing clients for receipts and statements, re-asking, reconciling who sent what. It came up four separate times, with specifics, a client who took three weeks to send a bank statement, a junior who quit partly over the chasing. The second-ranked problem was capacity visibility: the partner can't see who on the team is overloaded until something slips. They raised it twice, with feeling but less detail. Third, mentioned once near the end: clunky client onboarding. The generic demo opens with the dashboard, "here's your command center", then walks the feature menu left to right: onboarding, document management, capacity planning, reporting, integrations. The partner's number-one pain shows up third, sandwiched between things they care about less, framed as one feature among many. The diagnostic demo opens cold on document collection. No tour, no dashboard preamble. "You told me your team loses days every month chasing clients for documents, let me show you exactly what that looks like here." Then you run the client portal, the automated reminder cadence, the status view that shows what's outstanding without anyone emailing. You let them ask about their three-week-bank-statement client specifically. You stay there until the problem is visibly, concretely solved on screen. Then, and only then, you move to capacity visibility, their second problem, and show the workload view. You spend real time, but less. Onboarding, their third and lightest, gets a brief showing. And the reporting module, the integrations gallery, the mobile app, none of which they raised, don't get shown at all, unless they ask. Two demos, same product, same length budget. One returns the buyer's words as a working solution in the order they confessed the pain. The other makes them sit through a tour and hope their problem comes up. The first one is the diagnosis confirmed on screen. The second is a brochure read aloud.
Section 6
What about the features they didn't ask about?
The obvious objection: "But our reporting is genuinely great, and they'd love it if they saw it. Aren't I leaving value on the table by cutting it?" Mostly, no, and here's the discipline that resolves it. The rule is "no slide without a symptom." If a screen doesn't map to a problem the buyer stated in discovery, it doesn't earn a place in the core demo. That's not because the feature is bad; it's because showing it costs you relevance and time, and buys you a "huh, neat" instead of a "yes, that's my problem solved." There's a real exception, and it's worth naming so the rule doesn't become dogma. Sometimes you know, from pattern-matching across similar firms, that a buyer has a problem they didn't surface, a latent symptom. The move there isn't to silently show the feature. It's to re-open diagnosis: "Firms your size usually struggle with X too, is that live for you?" If they say yes, X just became a stated problem and earns a slot. If they say no, you were right to keep it out. The demo stays a diagnosis; you've just extended it rather than abandoned it. What you never do is treat "they didn't ask" as "they don't know to ask, so I'll dazzle them." That's the tour instinct wearing a strategy costume. The buyer didn't rank that problem because it isn't hurting them, and a feature solving a non-problem is dead weight. Hold the symptom test. The unrequested features can live in the follow-up, in the post-demo follow-up that handles objections in writing, where they cost you nothing and can be tied to a "you mentioned you might also…" thread.
Section 7
Why this beats the self-serve trial, and what that proves
There's a school of thought that the best demo is no demo: let the buyer into a free trial and let the product sell itself. For low-ACV, simple products, fine. For anything with real complexity or stakes, the data is brutal. For enterprise deals over $50K ACV, demo-based approaches convert at 55–75%, while enterprise trials convert at 10–15% . That gap is not about product access, the trial gives more access, not less. It's about diagnosis. A trial hands the buyer the whole product and says "find your own value." A guided diagnostic demo does the opposite: it locates the buyer's specific problem and shows that one thing solved, removing the burden of self-evaluation. The trial makes the buyer do the diagnosis. The demo does it for them, which is exactly why it wins, and exactly why a tour-style demo forfeits the advantage. A tour is a guided trial with the same "figure out what matters to you" burden, just with a narrator. So the enterprise number isn't really an argument for demos over trials. It's an argument for diagnosis over self-service. A generic demo sits in an awkward middle, it has the cost of a live call and the relevance of a trial. The diagnostic demo is the only version that earns the format.
Section 8
The BGA framework: The Upside-Down Pyramid Demo
A repeatable way to build the demo so it continues the diagnosis instead of replacing it. Five steps. 1. Rank discovery before you build a single slide. Pull your 11–14 targeted discovery questions into a ranked list of stated problems, ordered by how much airtime the buyer gave each. Use a simple proxy: count how many times they returned to it and how specific they got. The output is a numbered hierarchy, Problem 1, Problem 2, Problem 3, not a flat list. If you can't rank them, your discovery wasn't deep enough; go back before you demo. 2. Map one demo segment to each problem, top-down. Slot 1 = the problem they talked about most. Slot 2 = second-most. Slot 3 = third. Build the walkthrough to open on Slot 1 cold, no tour, no dashboard preamble, and descend. The widest, heaviest problem gets the most attention and the best minutes. 3. Apply the symptom test ruthlessly. For every screen you're tempted to include, ask: does this map to a stated problem? If not, cut it from the core demo. The rule is "no slide without a symptom." Latent problems you suspect but they didn't name don't get shown silently, they get re-surfaced as a question first ("is X also live for you?"), and only earn a slot if the buyer confirms. 4. Narrate in their words, confirm out loud. Open each segment by quoting the problem back: "You said your team loses days chasing client documents, here's that, gone." This is the diagnosis being confirmed on screen. Aim to be roughly two-thirds talking, one-third listening, and let the top problem generate real conversation. Don't fear a demo that runs long because the buyer is engaged, winning demos run about 30% longer for exactly that reason . 5. Park the rest in the follow-up. Unrequested features, deeper functionality, the integration gallery, none of it gets forced into the live demo. It goes into a written follow-up tied to what they said. This keeps the demo a diagnosis and gives your follow-up a reason to exist. A rule of thumb for sizing: if you walk out of discovery with three ranked problems, your demo is three segments, weighted roughly 50/30/20 by time, opening on the heaviest. Anything beyond the third problem is usually noise in the live session and belongs in follow-up. For the scripts and the discovery-to-demo mapping sheet, the Template Pack has the worksheet you need to build this segment by segment.
Section 9
You're running the Upside-Down Pyramid Demo right when…
You're running it right when you could not deliver the same demo twice, because no two discovery rankings are identical, and when a colleague watching couldn't tell where your product's "best" feature lives, only where the buyer's biggest problem does. You open cold on their number-one pain without a tour. You can name, before the call, exactly which screens you're not going to show and why. The buyer interrupts you with "yes, that's exactly it" in the first ten minutes, not the last. And when the demo runs long, it's because they're asking edge-case questions about their own situation, the diagnosis deepening in real time, not because you're still clicking through features nobody asked for. If your demo would survive being handed to a different buyer unchanged, you're running a tour, not a diagnosis.